ARK Investment Management LLC - 30 Sep 2025 SCHEDULE 13G/A Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager
ARK Investment Management LLC
Reporting Manager
ARK Investment Management LLC
Security
CRISPR Therapeutics AG Common Stock
Symbol
CRSP
Shares outstanding
90,956,998 shares
Disclosed Ownership
9,786,973 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
04 Nov 2025, 16:48:34 UTC
Date of event
30 Sep 2025
Previous filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARK Investment Management LLC 11% 9,786,973 9,115,198 211,277 /s/ Kellen Carter Kellen Carter, Chief Compliance Officer
Catherine D. Wood 11% 9,786,973 0 9,326,475 /s/ Catherine D. Wood Catherine D. Wood, Chief Executive Officer, Chief Investment Officer